Copy
 
 
Probus - South Pacific

This is a special edition of the Active Retirees E-newsletter sent for the information of Probus Club members. This E-newsletter is sponsored and paid for by Edwards Lifesciences.

NewHeartValve.com.au

DON’T MISS THOSE SPECIAL MOMENTS!

ASK YOUR GP TO LISTEN TO YOUR HEART TODAY.

Whether it was walking the beat or his time in the tactical response group, placing the lives of those caught up in hostage situations in his hands, Jeff put his life on the line for the citizens of New South Wales for nearly 24 years. “I’ve been busy!”, Jeff quipped as he casually yet proudly mentioned that he had travelled the world as the security manager of INXS.

Behind this cool, brave, and charming veneer was a man who had been through more than his share of personal tribulations. One of the greatest threats to Jeff’s health wasn’t a crazed criminal or an overzealous fan trying in vain to lay a finger on Michael Hutchence. It was a little-known yet deadly heart disease known as aortic stenosis.

Aortic stenosis is one of the most common and severe heart valve diseases. It involves narrowing of the aortic valve, usually as result of a calcium build-up over time. The aortic valve allows blood to flow from the heart’s left chamber to the main artery in the body, the aorta. This narrowing impedes blood flow around the body1. Aortic stenosis is a progressive disease that, when severe and untreated, may take the lives of 50% of patients within two years2.

Further, despite cancer consistently being one of the top concerns for people across Australia, severe aortic stenosis has a five-year survival rate worse than metastatic breast, colorectal and lung cancers3,4. Approximately one-third of patients experience no symptoms, allowing aortic stenosis to escape attention for several years before symptoms gradually or rapidly appear5.


WATCH: WHAT IS AORTIC STENOSIS?

 
NewHeartValve.com.au
 

When these symptoms eventually appear, they can indicate the disease has progressed to the severe stage. These symptoms include breathlessness, chest pain, fatigue, palpitations and feeling dizzy or faint6. On experiencing symptoms, Jeff stated, “I was lucky if I could walk without experiencing some chest pain. I felt limited.” The way these symptoms deteriorated Jeff and his wife Carol’s quality of life was also stark. “I was slowly declining, couldn’t walk and always had to know where I was going.”

However, even when symptoms do appear, like in Jeff’s case, these symptoms are often dismissed as age-related. Further, according to a YouGov survey conducted in 2020, 40% of Australians over 60 had never or rarely had their heart listened to7. In 2021, of the approximately 66,510 Australians suffering from severe symptomatic aortic stenosis, 53,427 were either left untreated or undiagnosed8,9.

If found quickly, successful treatment options exist for the severe form of aortic stenosis. These treatments can involve the replacement of the aortic valve via surgery or a less invasive procedure with a rapid recovery time. Consultation with a GP and specialist will determine the best option for you.

When Jeff asked his GP to listen to his heart with a stethoscope, the result was life-saving for Jeff and life-changing for both Jeff and Carol. Carol exclaimed, “We went from worry to knowing we can live again!”.

So, if you are over 65 and a GP’s stethoscope hasn’t listened to your heart recently or at all, don’t miss those special moments this Christmas or in 2023. Take that one small step that could save your life – ask a GP to listen to your heart today!

For more information on aortic stenosis, chat with your healthcare professional and click here for your free infokit.

 
Find our more
 

Information on this material includes educational information regarding certain conditions and potential therapies or treatment options. Other therapies or treatment options may be available, and you should discuss any educational information you access online with your healthcare professional. Appropriate treatment for individuals is a matter for healthcare professionals to decide in consultation with each individual.

NewHeartValve.com.au and the design logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

© 2022 Edwards Lifesciences Corporation. All rights reserved. AU-2022-357

Edwards Lifesciences Pty Ltd. 2/40 Talavera Road, Macquarie Park, NSW 2113, Australia. Phone: 1800 222 601.

 
  1. Carabello BA. Introduction to aortic stenosis. Circ Res 2013;113:179–85
  2. Otto CM. Timing of aortic valve surgery. Heart 2000;84:211-8
  3. Watanabe Y, Kozuma K, Hioki H, et al. Comparison of Results of Transcatheter Aortic Valve Implantation in Patients With Versus Without Active Cancer. Am J Cardiol. 2016;118(4):572-577
  4. National Cancer Institute. Cancer statistics based on data from the Surveillance, Epidemiology and End Results (SEER) program SEER 19
  5. 2009-2015. Volume 2019. Available at: https://seer.cancer.gov
  6. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery
 
  1. Mayo Clinic Staff. www.mayoclinic.com http://www.mayoclinic.org/ diseases-conditions/aortic-stenosis/basics/symptoms/con-20026329. Accessed August 12, 2016
  2. According to a survey Heart Health - Australia conducted by YouGov (2020) of 2077 Australians over the age of 60 years old, commissioned by Edwards Lifesciences on 6- 19 October 2020 [unpublished raw data]
  3. Ipsos AS Patient Drop-off Australia New Zealand, March 2021
  4. Strange et al, BMC 2021
 
 
 
CONNECT WITH US fb insta
 
TOP OF PAGE / PROBUS WEBSITE
 
 
Probus
Probus South Pacific Limited
PO Box 1294, Parramatta NSW 2124
T: (02) 9689 0200
1300 630 488 (Australia)
0800 14776 287 (New Zealand)
E: admin@probussouthpacific.org
W: www.probussouthpacific.org
 
Copyright Probus South Pacific Ltd. 2022.
All rights reserved. ACN 152 374 395
 
UPDATE YOUR DETAILS | UNSUBSCRIBE
CONTACT EDITOR | CONTACT PROBUS
PRIVACY POLICY
 
  Any information you provide to Probus South Pacific Limited (PSPL) will be collected, managed and used in accordance with PSPL’s Privacy Policy which can be accessed here. By providing your information you consent to its use in accordance with the Privacy Policy. Any sponsored content is provided and paid for by the advertiser. The information provided in this publication is of a general nature only and should not be considered as a recommendation or endorsement by PSPL of any product, service or advice contained in this publication. Please consider your personal circumstances and seek professional advice, if necessary. Recipients of this publication should ensure they review any terms, conditions and disclaimers provided by advertisers.